Ocugen, Inc.
DE ˙ DB ˙ US67577C1053
1,13 € ↓ -0,02 (-2,09%)
2026-06-04
DEL PRIS
SecurityDE:2H51 / Ocugen, Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership0 shares
Ownership 0.00%
Vanguard Group Inc ownership in 2H51 / Ocugen, Inc.

2026-03-27 - Vanguard Group Inc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Ocugen, Inc. (DE:2H51). This represents 0.0 percent ownership of the company. In their previous filing dated 2026-01-30 , Vanguard Group Inc had reported owning 16,475,562 shares, indicating a decrease of -100.00 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-03-27 2026-03-27 13G/A 16,475,562 0 -100.00 0.00 -100.00
2026-01-30 2026-01-30 13G 15,223,585 16,475,562 8.22 5.27 8.21
2025-10-31 2025-10-31 13G/A 16,949,019 15,223,585 -10.18 4.87 -17.18
2024-11-12 2024-11-12 13G/A 16,949,019 16,949,019 0.00 5.88 0.00
2024-11-04 2024-11-04 13G/A 12,039,918 16,949,019 40.77 5.88 25.37
2024-02-13 2024-02-13 13G/A 11,859,143 12,039,918 1.52 4.69 -13.47
2023-02-09 2023-02-09 13G/A 10,605,494 11,859,143 11.82 5.42 1.88
2022-02-10 2022-02-10 13G/A 9,074,993 10,605,494 16.87 5.32 -5.00
2021-02-10 2021-02-10 13G 9,074,993 5.60

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F OCUGEN COM 67577C105 16,475,562 1,251,977 8.22 22,242 -10.37 0.0003
2025-11-07 2025-09-30 13F OCUGEN COM 67577C105 15,223,585 450,904 3.05 24,814 73.17 0.0004
2025-08-11 2025-06-30 13F OCUGEN COM 67577C105 14,772,681 -1,910,432 -11.45 14,330 21.66 0.0002
2025-05-09 2025-03-31 13F OCUGEN COM 67577C105 16,683,113 64,020 0.39 11,778 -11.96 0.0002
2025-02-11 2024-12-31 13F OCUGEN COM 67577C105 16,619,093 -329,926 -1.95 13,378 -20.43 0.0002
2024-11-13 2024-09-30 13F OCUGEN COM 67577C105 16,949,019 1,427,852 9.20 16,813 -30.11 0.0003
2024-08-13 2024-06-30 13F OCUGEN COM 67577C105 15,521,167 3,521,616 29.35 24,058 22.25 0.0005
2024-05-10 2024-03-31 13F OCUGEN COM 67577C105 11,999,551 -40,367 -0.34 19,679 184.30 0.0004
2024-03-11 2023-12-31 13F/A-1 OCUGEN COM 67577C105 12,039,918 114,366 0.96 6,923 45.12 0.0002
2024-02-14 2023-12-31 13F OCUGEN COM 67577C105 12,039,918 114,366 6,923 0.0002
2023-12-18 2023-09-30 13F/A-1 OCUGEN COM 67577C105 11,925,552 119,207 1.01 4,770 -25.61 0.0001
2023-11-14 2023-09-30 13F OCUGEN COM 67577C105 11,925,552 119,207 4,770 0.0001
2023-08-14 2023-06-30 13F OCUGEN COM 67577C105 11,806,345 -1,208,505 -9.29 6,412 -42.24 0.0002
2023-07-14 2023-03-31 13F/A-1 OCUGEN COM 67577C105 13,014,850 1,155,707 9.75 11,103 -27.98 0.0003
2023-05-15 2023-03-31 13F OCUGEN COM 67577C105 13,014,850 1,155,707 11,103 0.0003
2023-02-10 2022-12-31 13F OCUGEN COM 67577C105 11,859,143 157,591 1.35 15,417 -25.99 0.0004
2022-11-14 2022-09-30 13F OCUGEN COM 67577C105 11,701,552 283,751 2.49 20,829 -19.64 0.0006
2022-08-12 2022-06-30 13F OCUGEN COM 67577C105 11,417,801 511,244 4.69 25,918 -27.99 0.0007
2022-05-13 2022-03-31 13F OCUGEN COM 67577C105 10,906,557 301,063 2.84 35,991 -25.41 0.0009
2022-02-14 2021-12-31 13F OCUGEN COM 67577C105 10,605,494 -268,393 -2.47 48,255 -38.19 0.0011
2021-11-12 2021-09-30 13F OCUGEN COM 67577C105 10,873,887 486,356 4.68 78,074 -6.40 0.0019
2021-08-13 2021-06-30 13F OCUGEN COM 67577C105 10,387,531 2,283,004 28.17 83,412 51.58 0.0021
2021-05-14 2021-03-31 13F OCUGEN COM 67577C105 8,104,527 -970,466 -10.69 55,029 231.36 0.0015
2021-02-12 2020-12-31 13F OCUGEN COM 67577C105 9,074,993 1,637,426 22.02 16,607 620.16 0.0005
2020-11-16 2020-09-30 13F OCUGEN COM 67577C105 7,437,567 7,108,182 2,158.02 2,306 3,058.90 0.0001
2020-08-14 2020-06-30 13F OCUGEN COM 67577C105 329,385 0 0.00 73 -21.51 0.0000
2020-05-15 2020-03-31 13F OCUGEN COM 67577C105 329,385 167,281 103.19 93 10.71 0.0000
2020-02-14 2019-12-31 13F OCUGEN COM 67577C105 162,104 145,446 873.13 84 75.00 0.0000
2019-11-14 2019-09-30 13F OCUGEN COM 67577C105 16,658 -982,817 -98.33 48 -74.87 0.0000
2019-08-14 2019-06-30 13F HISTOGENICS COM 43358V109 999,475 -2,425,491 -70.82 191 -51.77 0.0000
2019-05-15 2019-03-31 13F HISTOGENICS COM 43358V109 3,424,966 1,580,148 85.65 396 142.94 0.0000
2019-02-14 2018-12-31 13F HISTOGENICS COM 43358V109 1,844,818 929,647 101.58 163 -67.33 0.0000
2018-12-13 2018-09-30 13F/A-2 HISTOGENICS COM 43358V109 915,171 -7,998 -0.87 499 -78.37 0.0000
2018-11-23 2018-09-30 13F/A-1 HISTOGENICS COM 43358V109 915,171 0 499 0.0000
2018-11-14 2018-09-30 13F HISTOGENICS COM 43358V109 915,171 -7,998 499
2018-08-14 2018-06-30 13F HISTOGENICS COM 43358V109 923,169 528 0.06 2,307 -9.07 0.0001
2018-05-15 2018-03-31 13F HISTOGENICS COM 43358V109 922,641 534,251 137.56 2,537 218.72 0.0001
2018-02-14 2017-12-31 13F HISTOGENICS COM 43358V109 388,390 49,355 14.56 796 18.63 0.0000
2017-11-14 2017-09-30 13F HISTOGENICS COM 43358V109 339,035 61,301 22.07 671 34.20 0.0000
2017-08-24 2017-06-30 13F/A-1 HISTOGENICS COM 43358V109 277,734 0 0.00 500 3.95 0.0000
2017-08-11 2017-06-30 13F HISTOGENICS COM 43358V109 277,734 0 500
2017-05-12 2017-03-31 13F HISTOGENICS COM 43358V109 277,734 277,734 481 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.